Pak Cheong Sin
Direktor/Vorstandsmitglied bei YESASIA HOLDINGS LIMITED
Vermögen: - $ am 31.05.2024
Aktive Positionen von Pak Cheong Sin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
YESASIA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 19.06.2021 | - |
Independent Dir/Board Member | 19.06.2021 | - | |
Belief Biomed Ltd. | Corporate Officer/Principal | 01.04.2022 | - |
Karriereverlauf von Pak Cheong Sin
Ehemalige bekannte Positionen von Pak Cheong Sin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HiFiBiO Inc.
HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Finanzdirektor/CFO | 01.11.2020 | 01.08.2021 |
Orient Securities Investment Banking Co., Ltd.
Orient Securities Investment Banking Co., Ltd. Investment Banks/BrokersFinance Part of Orient Securities Co., Ltd., Orient Securities Investment Banking Co., Ltd. is a Chinese company that provides securities brokerage services. The company is based in Shanghai, China. The company was founded in 2012. Ji Ma has been the CEO of the company since 2012. Orient Securities Investment Banking Co. was acquired by Orient Securities Co., Ltd. from Citigroup Global Markets Asia Ltd. on April 22, 2020 for $69.43 million. | Corporate Officer/Principal | 01.03.2013 | 01.11.2020 |
Citigroup Global Markets Asia Ltd.
Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Corporate Officer/Principal | 01.09.2009 | 01.02.2013 |
UBS GROUP AG | Corporate Officer/Principal | 01.06.2006 | 01.12.2008 |
DEUTSCHE BANK AG | Corporate Officer/Principal | 01.08.2003 | 01.06.2006 |
Ausbildung von Pak Cheong Sin
Dartmouth College | Undergraduate Degree |
Statistik
International
Hong Kong | 4 |
Vereinigte Staaten | 3 |
Deutschland | 2 |
Operativ
Corporate Officer/Principal | 5 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Finance | 5 |
Consumer Services | 2 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
DEUTSCHE BANK AG | Finance |
UBS GROUP AG | Finance |
YESASIA HOLDINGS LIMITED | Technology Services |
Private Unternehmen | 4 |
---|---|
Citigroup Global Markets Asia Ltd.
Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Finance |
Orient Securities Investment Banking Co., Ltd.
Orient Securities Investment Banking Co., Ltd. Investment Banks/BrokersFinance Part of Orient Securities Co., Ltd., Orient Securities Investment Banking Co., Ltd. is a Chinese company that provides securities brokerage services. The company is based in Shanghai, China. The company was founded in 2012. Ji Ma has been the CEO of the company since 2012. Orient Securities Investment Banking Co. was acquired by Orient Securities Co., Ltd. from Citigroup Global Markets Asia Ltd. on April 22, 2020 for $69.43 million. | Finance |
HiFiBiO Inc.
HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Health Technology |
Belief Biomed Ltd. |
- Börse
- Insiders
- Pak Cheong Sin
- Erfahrung